Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials

Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials

Background and Objective: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, that is, characterized by cognitive decline. To date, there are no effective treatments for AD. Therefore, the objective of this study was to map new perspectives on the effects of pharmacological treatme...

Full description

Bibliographic Details
Main Authors:	Inmaculada Xu Lou, Jiayue Chen, Kamran Ali, Abdul Lateef Shaikh, Qilan Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Pharmacology
Subjects:	Alzheimer disease cognition pharmacology treatment latest research beta-amyloid
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1190604/full

Similar Items

Effect of nutrition in Alzheimer’s disease: A systematic review
by: Inmaculada Xu Lou, et al.
Published: (2023-05-01)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
by: Gerald Koelsch
Published: (2017-10-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function
by: Erin E. Sundermann, et al.
Published: (2023-06-01)

18F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
by: Yan Chang, et al.
Published: (2020-07-01)

Modern pharmacological models of Alzheimer’s disease
by: V. V. Kolobov, et al.
Published: (2017-02-01)

Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer’s Disease
by: Simon W. So, et al.
Published: (2023-05-01)

Olfactory Dysfunction Is Associated with Cerebral Amyloid Deposition and Cognitive Function in the Trajectory of Alzheimer’s Disease
by: Sheng-Min Wang, et al.
Published: (2023-08-01)

Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
by: Sonja Prpar Mihevc, et al.
Published: (2019-06-01)

Exploring the links among peripheral immunity, biomarkers, cognition, and neuroimaging in Alzheimer's disease
by: Jie‐Qiong Li, et al.
Published: (2023-10-01)

Computer-based cognitive tests and cerebral pathology among Japanese older adults
by: Hiroyuki Shimada, et al.
Published: (2023-04-01)

Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue
by: Sylvain E. Lesne
Published: (2014-11-01)

VRADA training system as a non-pharmacological dual intervention to alleviate symptoms of the pathophysiology of Mild Cognitive Impairment
by: Eleni E. Tzekaki, et al.
Published: (2023-09-01)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
by: Jung Eun Park, et al.
Published: (2019-03-01)

Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
by: Chen Ma, et al.
Published: (2022-02-01)

Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease
by: Kaixuan Wang, et al.
Published: (2021-01-01)

Krill Oil Attenuates Cognitive Impairment by the Regulation of Oxidative Stress and Neuronal Apoptosis in an Amyloid β-Induced Alzheimer’s Disease Mouse Model
by: Ji Hyun Kim, et al.
Published: (2020-08-01)

The Role of Oxytocin in Alzheimer’s Disease and Its Relationship with Social Interaction
by: Junpei Takahashi, et al.
Published: (2023-10-01)

Abeta Peptide and Alzheimer's Disease [electronic resources]: Celebrating a Century of Research/
by: Barrow, Colin J., et al.
Published: (2007)

Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
by: Jinhua Wen, et al.
Published: (2021-09-01)

Study on early cognitive function in transgenic APP/PS-1/tau mice model of Alzheimer's disease
by: Li WANG, et al.
Published: (2015-05-01)

Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
by: Chloe G. McKee, et al.
Published: (2023-02-01)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
by: QinJie Li, et al.
Published: (2022-10-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

Mitochondrial Manipulation and the Quest for Alzheimer's Treatments
by: Russell H. Swerdlow
Published: (2015-04-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
by: Juanjuan Zhao, et al.
Published: (2017-07-01)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2020-03-01)

The role of astrocytes in amyloid production and Alzheimer's disease
by: Georgia R. Frost, et al.
Published: (2017-01-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
by: Betty Marije Tijms, et al.
Published: (2021-08-01)

Dynamic association between AT(N) profile and cognition mediated by cortical thickness in Alzheimer’s continuum
by: Jae-Won Jang, et al.
Published: (2020-01-01)

BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
by: Jun Pyo Kim, et al.
Published: (2021-10-01)

Longitudinal association between ß-amyloid accumulation and cognitive decline in cognitively healthy older adults: A systematic review
by: Camille Parent, et al.
Published: (2023-01-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer’s Disease
by: Chantal Vidal, et al.
Published: (2021-03-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease
by: Yunxing Ma, et al.
Published: (2022-07-01)

Therapeutic Effect of Erythropoietin on Alzheimer’s Disease by Activating the Serotonin Pathway
by: Kyu-Ho Shim, et al.
Published: (2022-07-01)

Repurposing Diltiazem for Its Neuroprotective Anti-Dementia Role against Intra-Cerebroventricular Streptozotocin-Induced Sporadic Alzheimer’s Disease-Type Rat Model
by: Ramesh Alluri, et al.
Published: (2023-08-01)

Investigation of pathogenetic mechanism, prevention and treatment of Alzheimer's disease via systemic approaches
by: Yan-jiang WANG, et al.
Published: (2018-01-01)